Search results
Promising Trial Results Show New Standards In Cancer Treatment And Diagnostics Are On The Horizon
Benzinga via Yahoo Finance· 1 day agoOn Monday, Moderna (NASDAQ: MRNA) and Merck & Co (NYSE: MRK) also reported durable efficiency of...
Moderna Receives U.S. FDA Approval for RSV Vaccine mRESVIA(R)
The Joplin Globe· 6 days agomRESVIA is Moderna's second approved product and the only RSV vaccine available in single-dose pre-filled syringes
US approves Moderna's RSV vaccine for older adults
AFP via Yahoo News· 6 days agoThe US Food and Drug Administration on Friday approved Moderna's respiratory syncytial virus (RSV) vaccine for older adults -- marking the first time any...
Is Moderna Stock A Buy As The U.S. Government Mulls Its Bird Flu Vaccine?
Investor's Business Daily· 6 days agoIf approved, Moderna plans to launch its RSV vaccine this fall for people age 60 and older, rivaling...
Experimental mRNA vaccines gain steam with promising cancer trial results
Semafor via Yahoo News· 2 days agoMelanoma patients who received monthly mRNA vaccines and...the US Food and Drug Administration for...
The Sustained, Slow Declining, Blood Concentration Profile of NV-387 Enables Infrequent Dosing for...
St. Joseph News-Press· 2 days agoThe Company has found that its lead nanoviricide broad-spectrum antiviral drug candidate NV-387,...
1 Beaten-Down S&P 500 Dividend Stock to Buy in June and Hold For a Decade or Longer
Motley Fool via Yahoo Finance· 2 days agoThat was an 81% risk reduction compared to trial participants who were randomized to receive...
What To Know About Personalized mRNA Cancer Vaccines After Promising Trials From Moderna And Merck
Forbes· 2 days agoCancer vaccines are finally showing promise as Moderna and Merck touted promising data on an...
Alaska health officials point to wastewater sampling as useful disease-tracking tool
Alaska Public Radio Network· 6 days agoTesting at Anchorage’s John M. Asplund Wastewater Treatment Facility, the municipality’s main...
TIME100 Most Influential Companies 2024: Pfizer
Time Magazine· 7 days agoFind out why Pfizer is on the list